MET inhibitor resistance in patients with MET exon 14-altered lung cancers.

Guo, R; Offin, M; Brannon, AR; Chow, A; Delasos, L; Somwar, R; Wilkins, O; Scott, K; Tian, Y; Cecchi, F; Hembrough, TA; Li, BT; Rudin, CM; Kris, MG; Arcila, ME; Rekhtman, N; Paik, PK; Ladanyi, M; Zehir, A; Drilon, AE

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):